Home » Topics » BioWorld Science

BioWorld Science
RSS

Altimmune updates NasoVAX and HepTcell programs

March 28, 2018

KIFC1 a potentially new and druggable target for colorectal carcinoma

March 28, 2018

Japanese Sakigake designation granted to cancer programs

March 28, 2018

Aurigene Discovery Technologies presents novel VISTA protein inhibitors

March 28, 2018

Shanghai Institute Materia Medica, Shanghai Haihe Pharmaceutical divulge new EZH2 inhibitors

March 28, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents thrombopoietin receptor agonists

March 28, 2018

Novel metabotropic glutamate mGlu7 receptor agonists synthesized at Takeda

March 28, 2018

Sirenas describes novel cyclic peptide analogues

March 28, 2018

Krystal files IND with FDA for phase I/II study of KB-103 for dystrophic EB

March 28, 2018

FDA grants breakthrough therapy designation to Pedmark

March 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...